FTO overexpression in leukemia can also generate a resistant phenotype against EGFR TKIs [15,32], and its downregulation resensitizes melanoma cells to interferon gamma (IFN-γ) and anti-programmed cell death protein 1 (PD1) [15,27]. This evidence concerns the gene FTO and melanoma.